Cochlear
5
35M
3
0.12
1
0.40
- Areas of investment
Summary
Cochlear appeared to be the Corporate Investor, which was created in 1982. The main department of described Corporate Investor is located in the Sydney. The company was established in Australia.
The top activity for fund was in 2018. Deals in the range of 50 - 100 millions dollars are the general things for fund. The fund is generally included in less than 2 deals every year. Considering the real fund results, this Corporate Investor is 5 percentage points more often commits exit comparing to other organizations.
The typical case for the fund is to invest in rounds with 9-10 participants. Despite the Cochlear, startups are often financed by New Enterprise Associates, Lightstone Ventures, Aisling Capital. The meaningful sponsors for the fund in investment in the same round are Vertex Ventures HC, Vertex Ventures, New Enterprise Associates. In the next rounds fund is usually obtained by CRG L.P., Windham Venture Partners, Vertex Ventures HC.
Among the most popular portfolio startups of the fund, we may highlight Earlens Corporation, Nyxoah. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no exact preference in some founders of portfolio startups. Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Medical Device, Medical.
Investments analytics
Analytics
- Total investments
- 5
- Lead investments
- 1
- Rounds per year
- 0.12
- Follow on index
- 0.40
- Investments by industry
- Health Care (5)
- Medical (4)
- Medical Device (4)
- Neuroscience (2)
- Biotechnology (1) Show 1 more
- Investments by region
-
- United States (2)
- Belgium (2)
- Australia (1)
- Peak activity year
- 2020
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 11
- Group Appearance index
- 0.80
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Earlens Corporation | 05 Jun 2017 | Health Care, Medical Device, Medical | Late Stage Venture | 73M | United States, California |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.